Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX® Modified Release Tablets Administered to Patients Undergoing Colonoscopy

Trial Profile

Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX® Modified Release Tablets Administered to Patients Undergoing Colonoscopy

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Sep 2017

At a glance

  • Drugs Methylthioninium chloride-Cosmo (Primary)
  • Indications Colorectal cancer
  • Focus Diagnostic use
  • Acronyms CRO-11-108
  • Sponsors Cosmo Technologies
  • Most Recent Events

    • 23 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top